Compositions of phosphorylated tau peptides and uses thereof
US11958889B2 · kind B2 · utility
0Cited by
8References
24Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 24, 2018 |
| Grant date | Apr 16, 2024 |
| Priority date | — |
| Expiry date | Aug 7, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/627
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Liposomes containing tau peptides, preferably phosphorylated tau peptides, and conjugates containing tau peptides, preferably phosphorylated tau peptides, conjugated to an immunogenic carrier are described. Pharmaceutical compositions and uses of the liposomes and/or conjugates for treating or preventing a neurodegenerative disease or disorder, such as Alzheimer's Disease, are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.